SRPT
Sarepta Therapeutics, Inc.
+0.70 (+3.54%)20.46USD898K成交股數2.2B市值–本益比(近四季)1.7股價營收比-35.9%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 329M-36% | 331M-46% | 443M-33% | 370M-14% | 513M+42% | 612M+70% | 658M+113% | 430M+80% | 361M | 359M | 309M | 239M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | −29.1M-106% | 219M-35% | 361M+14% | 474M+53% | 506M | 338M | 316M | 309M | – | – |
| 毛利率 | – | – | -6.6% | 59.3% | 70.3% | 77.5% | 76.8% | 78.7% | 87.6% | 85.9% | – | – |
| 研發費用 | 91.3M | 154M | – | 219M | 204M | 773M | – | 224M | 180M | 200M | 194M | 242M |
| 銷售管理費用 | 108M | 109M | – | 91.9M | 138M | 134M | – | 128M | 139M | 127M | 121M | 119M |
| 營業利益 | 13.3M-89% | 358M-219% | – | −103M-566% | 116M-16587% | −300M-961% | – | 22.2M-117% | −701K | 34.9M | −20.8M | −134M |
| 營業利益率 | 4.0% | 108.4% | – | -27.9% | 22.5% | -49.1% | – | 5.2% | -0.2% | 9.7% | -6.7% | -55.9% |
| 稅後淨利 | −4.9M-102% | 331M-174% | −412M-359% | −50.6M-250% | 197M+2948% | −448M-1339% | 159M-489% | 33.6M-240% | 6.5M | 36.1M | −40.9M | −23.9M |
| 淨利率 | -1.5% | 100.1% | -93.1% | -13.7% | 38.4% | -73.2% | 24.2% | 7.8% | 1.8% | 10.0% | -13.2% | -10.0% |
| 稀釋 EPS | -0.05-103% | 2.88-163% | -3.93-362% | -0.50-247% | 1.89+2600% | -4.60-1343% | 1.50-426% | 0.34-226% | 0.07 | 0.37 | -0.46 | -0.27 |
| 稀釋股數 | 105M | 122M | – | 100M | 107M | 97.4M | – | 100M | 99.1M | 99.1M | 88.9M | 88.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 571M | 464M | 801M | 613M | 511M | 241M | 1.1B | 198M | 384M | 427M | 542M | 852M |
| 應收帳款 | 377M | 395M | 398M | 396M | 527M | 659M | 602M | 435M | 360M | 379M | 319M | 237M |
| 存貨 | 904M | 1.0B | 915M | 1.1B | 994M | 941M | 750M | 566M | 486M | 374M | 244M | 227M |
| 總資產 | 3.2B | 3.2B | 3.3B | 3.5B | 3.7B | 3.5B | 4.0B | 3.6B | 3.4B | 3.2B | 3.1B | 3.1B |
| 有息負債 | 848M | 838M | 829M | 141M | – | – | 1.1B | 1.2B | 1.2B | 1.2B | 1.2B | 1.2B |
| 總負債 | 1.7B | 1.7B | 2.2B | 2.2B | 2.3B | 2.3B | 2.4B | 2.4B | 2.3B | 2.3B | 2.3B | 2.4B |
| 股東權益 | 1.5B | 1.5B | 1.1B | 1.3B | 1.4B | 1.2B | 1.5B | 1.2B | 1.1B | 961M | 764M | 741M |
| 負債比 | 52.1% | 52.7% | 65.9% | 62.2% | 63.1% | 67.0% | 61.5% | 66.1% | 68.5% | 70.2% | 75.4% | 76.3% |
| 淨現金(現金 − 有息負債) | −276M | −374M | −27.7M | 473M | – | – | −34.1M | −1.0B | −843M | −812M | −695M | −384M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −203M-65% | – | – | – | −583M+141% | – | – | – | −242M | – | – |
| 資本支出 | – | 2.1M | – | – | – | 43.7M | – | – | – | 32.4M | – | – |
| 自由現金流 | – | −205M-67% | – | – | – | −627M+128% | – | – | – | −275M | – | – |
| 折舊攤銷 | – | 10.6M | – | – | – | 10.0M | – | – | – | 8.7M | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -62.0% | – | – | – | -102.5% | – | – | – | -76.4% | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 2.2B
| All Other Segments | 2.2B | 100.0% | +15.6% |
|---|
產品／服務2025 年度 · 1.9B
| Pmo Products | 966M | 51.8% | -0.2% |
|---|---|---|---|
| Elevidys | 899M | 48.2% | +9.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.9B | +4.3% | −713M | -38.3% | -7.13 | −307M |
| FY2024 | 1.8B | +56.2% | 235M | 13.2% | 2.34 | −343M |
| FY2023 | 1.1B | +35.7% | −536M | -46.8% | -5.80 | −577M |
| FY2022 | 844M | +37.8% | −703M | -83.4% | -8.03 | −356M |
| FY2021 | 612M | +34.3% | −419M | -68.4% | -5.15 | −482M |
| FY2020 | 456M | +19.7% | −554M | -121.6% | -7.11 | 25.3M |
| FY2019 | 381M | +26.5% | −715M | -187.8% | -9.71 | −516M |
| FY2018 | 301M | – | −362M | -120.2% | -5.46 | −450M |